threonine and Budd-Chiari Syndrome

threonine has been researched along with Budd-Chiari Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Darwish Murad, S; de Bruijne, EL; de Maat, MP; Haagsma, EB; Janssen, HL; Leebeek, FW; Rosendaal, FR; Tanck, MW; van Hoek, B	1

Other Studies

1 other study(ies) available for threonine and Budd-Chiari Syndrome

Article	Year
Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis. Thrombosis and haemostasis, 2007, Volume: 97, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine; Budd-Chiari Syndrome; Carboxypeptidase B2; Case-Control Studies; Female; Genetic Predisposition to Disease; Genetic Variation; Haplotypes; Humans; Male; Middle Aged; Netherlands; Odds Ratio; Polymorphism, Single Nucleotide; Portal Vein; Risk Factors; Threonine; Venous Thrombosis	2007

Article

Year

Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis.

Thrombosis and haemostasis, 2007, Volume: 97, Issue:2

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine; Budd-Chiari Syndrome; Carboxypeptidase B2; Case-Control Studies; Female; Genetic Predisposition to Disease; Genetic Variation; Haplotypes; Humans; Male; Middle Aged; Netherlands; Odds Ratio; Polymorphism, Single Nucleotide; Portal Vein; Risk Factors; Threonine; Venous Thrombosis

2007